100+ Free AOBFP Family Medicine Practice Questions

Outpatient Adult Medicine

Hypertension management per ACC/AHA 2017 (stage 1 >=130/80; stage 2 >=140/90; first-line thiazide/ACEi-ARB/CCB). Type 2 diabetes per ADA 2026 (metformin first-line; SGLT2 inhibitors first-line for CKD with albuminuria or HFrEF/HFpEF; GLP-1 RAs for ASCVD). Dyslipidemia (high-intensity statin if LDL >=190, ASCVD, or DM 40-75 with ASCVD risk; moderate-intensity for primary prevention >=7.5% risk). USPSTF preventive screening (colorectal at 45, lung CT 50-80 with 20 pack-year history, cervical 21-65, breast 40-74 biennial, AAA in men 65-75 ever-smokers). Respiratory (asthma GINA, COPD GOLD LAMA/LABA/ICS), GI (GERD, Barrett's surveillance every 3-5 years for non-dysplastic), endocrine (Hashimoto's, Graves'), infections (cellulitis cephalexin, uncomplicated UTI nitrofurantoin, latent TB 3HP or 4R, atypical pneumonia macrolide), and dermatology.

Pediatrics

Well-child care visit schedule and Bright Futures, AAP/ACIP routine immunization schedule (DTaP, IPV, Hib, PCV, RV, HepB, MMR at 12-15 months, varicella, HPV starting age 9-11, Tdap at 11-12, influenza annually), growth charts and developmental milestones (CDC 'Learn the Signs Act Early'), common acute infections (acute otitis media -- high-dose amoxicillin first-line; croup -- dexamethasone + nebulized racemic epinephrine; bronchiolitis -- supportive; pediatric pneumonia), pediatric asthma maintenance (low-dose ICS for persistent), ADHD per AAP 2019 (behavioral first-line under age 6; stimulants methylphenidate or amphetamine + behavioral 6-12), autism spectrum (M-CHAT-R screening 18 and 24 months), pediatric obesity, sports preparticipation 14-element AHA exam, and safe-sleep (supine, firm flat surface, room-share without bed-sharing).

Osteopathic Principles & Practice (OMM)

Four tenets of osteopathic medicine: (1) body is a unit; (2) self-regulatory and self-healing mechanisms; (3) structure and function reciprocally interrelated; (4) rational treatment based on these. Fryette principles -- Type I (group, neutral; side-bending and rotation OPPOSITE sides) vs Type II (single-segment, non-neutral; side-bending and rotation SAME side). OMT modalities -- HVLA (direct thrust through restrictive barrier), muscle energy (patient isometric contraction against physician resistance), counterstrain (90-second tender-point hold), myofascial release, balanced ligamentous tension (BLT), Still technique (combined indirect-to-direct), facilitated positional release. Cranial -- primary respiratory mechanism. Sacral diagnosis (R-on-R/L-on-L torsions, unilateral flexion/extension). Chapman points (e.g., appendix at tip of 12th rib right anterior; T11-T12 posterior right). Viscerosomatic reflexes -- cardiac T1-T5 left; small intestine T5-T9 (greater splanchnic). OMT billing CPT 98925-98929 by number of body regions treated. Contraindications -- HVLA contraindicated in fracture, osteoporosis, vertebral artery insufficiency, malignancy at site.

Women's Health & Maternity Care

Contraception -- LARCs (etonogestrel implant, levonorgestrel IUDs, copper IUD) are first-line with <1% failure rate; combined OCPs; emergency contraception (copper IUD most effective; ulipristal; levonorgestrel). Preconception -- folic acid 0.4 mg (4 mg for prior NTD), medication review (avoid valproate, ACEi/ARB, isotretinoin). Prenatal care -- first prenatal labs (CBC, blood type/Rh, HIV, syphilis, HepB, urine culture), GDM screening 24-28 weeks via 2-step (50-g 1-hour then 100-g 3-hour) or 1-step (75-g 2-hour). GBS rectovaginal swab 36-37 weeks. Routine labor and delivery management, postpartum follow-up. Breastfeeding and mastitis (dicloxacillin/cephalexin; continue breastfeeding). USPSTF cervical screening (cytology every 3 years 21-29; cytology every 3 years OR hrHPV every 5 years OR co-testing every 5 years for 30-65). Menopause/hormone therapy (NAMS most favorable <60 or within 10 years; reassess >5 years duration). Vasomotor symptoms -- paroxetine 7.5 mg FDA-approved non-hormonal; fezolinetant. Postmenopausal recurrent UTI -- vaginal estrogen.

Behavioral Health

Depression -- PHQ-9 screening; mild-moderate first-line SSRI plus CBT/IPT; postpartum depression (sertraline preferred in breastfeeding). Anxiety -- GAD-7. Bipolar I -- mania >=7 days; mood stabilizers (lithium narrow therapeutic 0.6-1.2 mEq/L, valproate teratogenic, lamotrigine SJS titration). Eating disorders -- inpatient stabilization for medical instability; refeeding syndrome (hypophosphatemia). Substance use -- AUDIT-C; AUD pharmacotherapy (naltrexone, acamprosate, disulfiram); OUD pharmacotherapy (buprenorphine/naloxone -- X-waiver eliminated 2022 MAT Act, methadone via OTP, naltrexone XR). Tobacco cessation -- varenicline most effective; bupropion; combination NRT (patch + lozenge/gum). Insomnia -- CBT-I first-line. Adolescent confidentiality -- protected for sensitive services within state law.

Geriatrics

Dementia workup (MoCA, basic labs TSH/B12/CBC/CMP, MRI to evaluate reversible causes); Alzheimer (cholinesterase inhibitors, memantine, anti-amyloid lecanemab/donanemab for early disease); Lewy body neuroleptic sensitivity; NPH triad (gait, incontinence, cognition). Delirium -- CAM; reversible causes (UTI, medications, dehydration); avoid benzodiazepines except for alcohol/BZD withdrawal. Polypharmacy -- Beers Criteria (avoid benzodiazepines, anticholinergics, long-acting hypnotics); deprescribing. Falls -- USPSTF Grade B exercise (tai chi, balance training). Osteoporosis -- DEXA T-score <=-2.5 or fragility fracture; bisphosphonates (alendronate -- take with full glass of water, remain upright 30 min); denosumab; teriparatide for severe disease. BPH/LUTS -- alpha-1 blockers (tamsulosin) plus 5-ARI for large glands. GCA -- start steroids before biopsy if vision symptoms. PMR -- low-dose prednisone.

Urgent Care & Procedures

STEMI -- aspirin 162-325 mg chewed, transfer to PCI-capable center, door-to-balloon <=90 minutes. NSTEMI -- DAPT, anticoagulation, risk stratification. Acute stroke -- IV alteplase/tenecteplase within 4.5 hours; mechanical thrombectomy up to 24 hours for LVO with imaging criteria. SVT -- vagal maneuvers, IV adenosine 6 mg then 12 mg. Trauma -- ATLS primary/secondary survey; FAST and CT for stable patients with positive FAST. HIV PEP -- 3-drug ART within 72 hours x 28 days. Lacerations and suturing, joint injections, IUD insertion, fracture splinting, skin biopsy, and ACLS basics.

Practice Management, Ethics & Quality

Informed consent and capacity assessment, advance directives (POLST, healthcare proxy), shared decision-making (PSA screening 55-69 individual decision), confidentiality and HIPAA, mandatory reporting (child/elder abuse, certain communicable diseases), OMT documentation and CPT 98925-98929 billing requirements (number of body regions, techniques, dysfunctions), MIPS quality measures, medical error disclosure, and DEA opioid prescribing requirements (PDMP check, MAT Act 2022 buprenorphine prescribing).